Hong Kong stock market anomaly | CanSinoBIO (09926.HK) surged more than 7% against the market. Data from the first-line treatment of advanced cervical cancer subgroup analysis will be released at ASCO 2025.

According to the Zhitong Finance and Economics APP, Conner Bio (09926.HK) bucked the market trend with a rise of over 7%. As of the time of writing, it was up 6.94% at 102.5 Hong Kong dollars, with a turnover of 744 million Hong Kong dollars.